Quantum BioPharma Consultant - Biotech Investor - IR Services - Business Marketing - Social Media Management
FSD Pharma has a remylenating drug called Lucid MS that can target all forms of MS. The idea exists that MS has a neurodegenerative component seperate from the auto immune aspect. Thus the need for remyelinating therapies for multiple sclerosis patients around the world. Any stakeholders that want more info reach out to me , including #investmentbanking community thanks.
Recap Video On Our Drug Candidate Lucid-MS targeting all forms of Multiple Sclerosis #Multiplesclerosis #Biotechnology #Nasdaq
